Synthesis and biological activities of a pH-dependently activated water-soluble prodrug of a novel hexacyclic camptothecin analog

被引:16
|
作者
Ohwada, Jun [1 ]
Ozawa, Sawako [1 ]
Kohchi, Masami [1 ]
Fukuda, Hiroshi [1 ]
Murasaki, Chikako [1 ]
Suda, Hitomi [1 ]
Murata, Takeshi [1 ]
Niizuma, Satoshi [1 ]
Tsukazaki, Masao [1 ]
Ori, Kazutomo [1 ]
Yoshinari, Kiyoshi [1 ]
Itezono, Yoshiko [1 ]
Endo, Mika [1 ]
Ura, Masako [1 ]
Tanimura, Hiromi [1 ]
Miyazaki, Yoko [1 ]
Kawashima, Akira [1 ]
Nagao, Shunsuke [1 ]
Namba, Eitarou [1 ]
Ogawa, Koutarou [1 ]
Kobayashi, Kazuko [1 ]
Okabe, Hisafumi [1 ]
Umeda, Isao [1 ]
Shimma, Nobuo [1 ]
机构
[1] Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan
关键词
Camptothecin analog; Topoisomerase I inhibitor; TP300; Antitumor agent; Water-soluble; Prodrug; Drug resistance; BCRP; ANTITUMOR-ACTIVITY; IRINOTECAN CPT-11; TOPOISOMERASE-I; METABOLITE; SN-38; GLUCURONIDATION; INHIBITION;
D O I
10.1016/j.bmcl.2009.03.123
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
CH0793076 (1) is a novel hexacyclic camptothecin analog showing potent antitumor activity in various human caner xenograft models. To improve the water solubility of 1, water-soluble prodrugs were designed to generate an active drug 1 nonenzymatically, thus expected to show less interpatient PK variability than CPT-11. Among the prodrugs synthesized, 4c (TP300, hydrochloride) having a glycylsarcosyl ester at the C-20 position of 1 is highly water-soluble (> 10 mg/ml), stable below pH 4 and rapidly generates 1 at physiological pH in vitro. The rapid (ca. < 1 min) generation of 1 after incubation of TP300 with plasma (mouse, rat, dog and monkey) was also demonstrated. TP300 showed a broader antitumor spectrum and more potent antitumor activity than CPT-11 in various human cancer xenograft models. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2772 / 2776
页数:5
相关论文
共 47 条
  • [2] Synthesis, characterization and biological activities of novel water-soluble metalloporphyrins
    Li, ZY
    Zhang, YN
    Gao, ZT
    Liu, Y
    Zhu, XJ
    CHINESE CHEMICAL LETTERS, 2001, 12 (12) : 1085 - 1088
  • [4] Study on synthesis and biological activities of novel water-soluble metalloporphyrins
    Li, Z.-Y.
    Zhang, Y.-N.
    Xiao, W.
    Zhu, X.-J.
    Gao, Z.-T.
    Liu, Y.
    Wuhan University Journal of Natural Sciences, 2001, 6 (04) : 841 - 845
  • [5] Design, Synthesis, and Biological Evaluation of a Novel Water-soluble Prodrug of Docetaxel with Amino Acid as a Linker
    Ma, Huan
    Chen, Gang
    Wang, Tao
    Li, Qingeng
    Liu, Yan
    CHEMICAL BIOLOGY & DRUG DESIGN, 2016, 88 (03) : 363 - 369
  • [6] Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT)
    Leu, YL
    Roffler, SR
    Chern, JW
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (18) : 3623 - 3628
  • [7] A novel approach of water-soluble paclitaxel prodrug with no auxiliary and no byproduct: Design and synthesis of isotaxel
    Hayashi, Y
    Skwarczynski, M
    Hamada, Y
    Sohma, Y
    Kimura, T
    Kiso, Y
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (18) : 3782 - 3784
  • [8] A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancer resistance protein-expressing tumor xenografts
    Endo, Mika
    Miwa, Masanori
    Ura, Masako
    Tanimura, Hiromi
    Taniguchi, Kenji
    Miyazaki, Yoko
    Ohwada, Jun
    Tsukazaki, Masao
    Niizuma, Satoshi
    Murata, Takeshi
    Ozawa, Sawako
    Suda, Hitomi
    Ogawa, Kotaro
    Nanba, Eitaro
    Nagao, Shunsuke
    Shimma, Nobuo
    Yamada-Okabe, Hisafumi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (02) : 363 - 371
  • [9] A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancer resistance protein-expressing tumor xenografts
    Mika Endo
    Masanori Miwa
    Masako Ura
    Hiromi Tanimura
    Kenji Taniguchi
    Yoko Miyazaki
    Jun Ohwada
    Masao Tsukazaki
    Satoshi Niizuma
    Takeshi Murata
    Sawako Ozawa
    Hitomi Suda
    Kotaro Ogawa
    Eitaro Nanba
    Shunsuke Nagao
    Nobuo Shimma
    Hisafumi Yamada-Okabe
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 363 - 371